相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
- 亚型:
IgG
- 形态:
liquid
- 保存条件:
负20摄氏度
- 克隆性:
Polyclonal antibody
- 标记物:
Non-conjugated
- 适应物种:
Human,Mouse ,Rat
- 保质期:
6个月
- 抗原来源:
Rabbit
- 目录编号:
P67936
- 级别:
纯化级别
- 库存:
50
- 供应商:
LSM bio
- 宿主:
E. coli - derived recombinant protein
- 应用范围:
ELISA,WB,IHC,IP
- 浓度:
≥95% as determined by SDS-PAGE
- 靶点:
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
- 抗体英文名:
anti-PIN1 antibody,PIN1 antibody
- 抗体名:
anti-PIN1 抗体,PIN1 抗体
- 规格:
100μg
PIN1抗体| PIN1 antibody
货号 PAab06457
蛋白别名
蛋白介绍
Peptidyl-prolyl cis/trans isomerase (PPIase) that binds to and isomerizes specific phosphorylated Ser/Thr-Pro (pSer/Thr- Pro) motifs in a subset of proteins, resulting in conformational changes in the proteins (PubMed:21497122, PubMed:22033920). Displays a preference for an acidic residue N-terminal to the isomerized proline bond. Regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity. Down-regulates kinase activity of BTK (PubMed:16644721). Can transactivate multiple oncogenes and induce centrosome amplification, chromosome instability and cell transformation. Required for the efficient dephosphorylation and recycling of RAF1 after mitogen activation (PubMed:15664191). Binds and targets PML and BCL6 for degradation in a phosphorylation-dependent manner (PubMed:17828269). Acts as a regulator of JNK cascade by binding to phosphorylated FBXW7, disrupting FBXW7 dimerization and promoting FBXW7 autoubiquitination and degradation: degradation of FBXW7 leads to subsequent stabilization of JUN (PubMed:22608923).
产品描述
anti-PIN1 antibody is a Rabbit Polyclonal antibody againstPIN1..
建议稀释比例
IHC
Immunohistochemistry of paraffin-embedded human renal cell carcinoma tissue slide using PAab06457( PIN1 Antibody) at dilution of 1:50
Western blot
HEK-293 cells were subjected to SDS PAGE followed by western blot with PAab06457(PIN1 antibody) at dilution of 1:1000(本抗体仅供体外科研用途,不可用于临床诊断!) "">
""> ""> ""> ""> ""> "">风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验攻克「癌症之王」!哈佛大学卢坤平团队提出消除肿瘤新方法,这个
胰腺癌是著名的「癌症之王」,其发病病程短、恶化速度快、死亡率高,不仅化疗、靶向治疗对它效果不佳,就连近年来最为火热的免疫治疗也对它束手无策。因此,发现一种让胰腺癌对化疗或免疫治疗更敏感的方法可能可以作为胰腺癌治疗的新策略。2021 年 8 月 12 日,来自哈佛大学医学院的卢坤平教授团队在 Cell 上在线发表了题为 Targeting Pin1 renders pancreatic cancer eradicable by synergizing
【求助】P53的翻译后修饰都有哪些? 怎样验证其修饰后与靶标启动子的结合活性的变化?
、Ser376)则和p53降解的增加有关。 顺反异构化修饰 p53的活化涉及构象的改变,由肽脯氨酰-顺反异构酶︱(PIN1)引起的特定的脯氨酸残基的顺反异构化可导致构象的改变。PIN1的蛋白结合位点包括一个磷酸化的丝氨酸或苏氨酸及其后紧跟的一个脯氨酸,从而催化脯氨酸残基发生顺反异构化。目前对Ser127-Pro128、Thr150-Pro151基序是否受PIN1的靶向作用还不清楚。PIN1引起的p53构象的改变阻止了MDM2的结合和/或促进了MDM2的解离,从而使
祝贺〖雅裕睿安〗成为Signalway Antibody(SAB)独家
祝贺〖上海雅裕 〗成为 Signalway Antibody 品牌 (SAB) 的独家总代理。 促销【 ABCD 】细则如下: 【 A 】 买两支 SAB 抗体免费获得 8G 优盘 活动时间:即日起,至 2011 年
技术资料暂无技术资料 索取技术资料








